Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Jun 10, 2022

Accession no.
0001209191-22-036008
Filed
Jun 10, 2022
Trade date
May 2-31, 2022
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $1.10K. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 2, 2022Common StockPPurchaseAcquired+20$2.45+$4916,011Direct
May 3, 2022Common StockPPurchaseAcquired+20$2.42+$48.416,031Direct
May 4, 2022Common StockPPurchaseAcquired+20$2.37+$47.416,051Direct
May 5, 2022Common StockPPurchaseAcquired+20$2.35+$4716,071Direct
May 6, 2022Common StockPPurchaseAcquired+20$2.36+$47.216,091Direct
May 9, 2022Common StockPPurchaseAcquired+23$2.63+$60.4916,114Direct
May 10, 2022Common StockPPurchaseAcquired+23$2.55+$58.6516,137Direct
May 11, 2022Common StockPPurchaseAcquired+23$2.37+$54.5116,160Direct
May 12, 2022Common StockPPurchaseAcquired+23$2.23+$51.2916,183Direct
May 13, 2022Common StockPPurchaseAcquired+23$2.32+$53.3616,206Direct
May 16, 2022Common StockPPurchaseAcquired+23$2.31+$53.1315,229Direct
May 17, 2022Common StockPPurchaseAcquired+23$2.35+$54.0516,252Direct
May 18, 2022Common StockPPurchaseAcquired+23$2.31+$53.1316,275Direct
May 19, 2022Common StockPPurchaseAcquired+23$2.29+$52.6716,298Direct
May 20, 2022Common StockPPurchaseAcquired+23$2.23+$51.2916,321Direct
May 23, 2022Common StockPPurchaseAcquired+25$2.17+$54.2516,346Direct
May 24, 2022Common StockPPurchaseAcquired+25$2.17+$54.2516,371Direct
May 25, 2022Common StockPPurchaseAcquired+25$2.15+$53.7516,396Direct
May 26, 2022Common StockPPurchaseAcquired+25$2.12+$5316,421Direct
May 27, 2022Common StockPPurchaseAcquired+25$2.13+$53.2516,446Direct
May 31, 2022Common StockPPurchaseAcquired+25$2.13+$53.2516,471Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)